Anti-obesity drugs: a review about their effects and their safety

Effects of One Year Treatment of Sibutramine on Insulin Resistance Parameters in Type 2 Diabetic Patients

(2016) Giuseppe Derosa et al.   JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES

L-Carnitine - Metabolic Functions and Meaning in Humans Life

(2011) Jolanta Pekala et al.   CURRENT DRUG METABOLISM

Exenatide or glimepiride added to metformin on metabolic control and on insulin resistance in type 2 diabetic patients

(2011) Giuseppe Derosa et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Effects of 1-year orlistat treatment compared to placebo on insulin resistance parameters in patients with type 2 diabetes

(2011) G. Derosa et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Randomized controlled trial to investigate the effects of a newly developed formulation of phentermine diffuse-controlled release for obesity

(2010) J. G. Kang et al.   DIABETES OBESITY & METABOLISM

Exenatide Versus Glibenclamide in Patients with Diabetes

(2010) G. Derosa et al.   Diabetes Technology & Therapeutics

Orlistat and L-carnitine compared to orlistat alone on insulin resistance in obese diabetic patients

(2010) Giuseppe Derosa et al.   ENDOCRINE JOURNAL

Comparison of orlistat treatment and placebo in obese type 2 diabetic patients

(2010) Giuseppe Derosa et al.   EXPERT OPINION ON PHARMACOTHERAPY

Comparison between orlistat plus l-carnitine and orlistat alone on inflammation parameters in obese diabetic patients

(2010) Giuseppe Derosa et al.   FUNDAMENTAL & CLINICAL PHARMACOLOGY

Sibutramine and L-Carnitine Compared to Sibutramine Alone on Insulin Resistance in Diabetic Patients

(2010) Giuseppe Derosa et al.   INTERNAL MEDICINE

Variation of inflammatory parameters after sibutramine treatment compared to placebo in type 2 diabetic patients

(2010) G. Derosa et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Effects of combination of sibutramine and l-carnitine compared with sibutramine monotherapy on inflammatory parameters in diabetic patients

(2010) Giuseppe Derosa et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects

(2010) W. Philip T. James et al.   NEW ENGLAND JOURNAL OF MEDICINE

The weight lowering effect of sibutramine and its impact on serum lipids in cardiovascular high risk patients with and without type 2 diabetes mellitus - an analysis from the SCOUT lead-in period

(2010) Peter Weeke et al.   BMC Endocrine Disorders

An Endocannabinoid Hypothesis of Drug Reward and Drug Addiction

(2009) Emmanuel S. Onaivi   Annals of the New York Academy of Sciences

The incidence of co-morbidities related to obesity and overweight: A systematic review and meta-analysis

(2009) Daphne P Guh et al.   BMC PUBLIC HEALTH

Comparison of the effects of sibutramine versus sibutramine plus metformin in obese women

(2009) Ramazan Sari et al.   CLINICAL AND EXPERIMENTAL MEDICINE

Orlistat 120 mg improves glycaemic control in type 2 diabetic patients with or without concurrent weight loss

(2009) S. Jacob et al.   DIABETES OBESITY & METABOLISM

Weight and blood pressure response to weight management and sibutramine in diabetic and non-diabetic high-risk patients: an analysis from the 6-week lead-in period of the sibutramine cardiovascular outcomes (SCOUT) trial

(2009) L. F. Van Gaal et al.   DIABETES OBESITY & METABOLISM

Cannabinoid receptor antagonists: pharmacological opportunities, clinical experience, and translational prognosis

(2009) David R Janero et al.   EXPERT OPINION ON EMERGING DRUGS

Early Response to Sibutramine in Patients Not Meeting Current Label Criteria: Preliminary Analysis of SCOUT Lead-in Period

(2009) Ian Caterson et al.   Obesity

SERENADE: The Study Evaluating Rimonabant Efficacy in Drug-Naive Diabetic Patients: Effects of monotherapy with rimonabant, the first selective CB1 receptor antagonist, on glycemic control, body weight, and lipid profile in drug-naive type 2 diabetes

(2008) J. Rosenstock et al.   DIABETES CARE

Endocannabinoids and the Control of Energy Homeostasis

(2008) George Kunos et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Sibutramine effect on metabolic control of obese patients with type 2 diabetes mellitus treated with pioglitazone

(2008) Giuseppe Derosa et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Methylphenidate Hydrochloride Increases Energy Expenditure in Healthy Adults

(2008) Claudio Lorello et al.   Obesity

Weight Loss Produced by Tesofensine in Patients With Parkinson's or Alzheimer's Disease

(2008) Arne Astrup et al.   Obesity

Rimonabant and Depression

(2008) M. Soyka   PHARMACOPSYCHIATRY

The Obesity Paradox: Impact of Obesity on the Prevalence and Prognosis of Cardiovascular Diseases

(2008) Surya M. Artham et al.   POSTGRADUATE MEDICINE

Elevated body mass index and fatty liver

(2008) Dragana Marovic   Srpski Arhiv za Celokupno Lekarstvo